MTHFR rs1056827: Homocysteine Dynamics and Vascular Health
rs1056827 is a single nucleotide polymorphism located within the methylenetetrahydrofolate reductase (MTHFR) gene. This genetic variant has been investigated for its potential role in modulating one-carbon metabolism, homocysteine levels, and vascular endothelial dynamics during high-intensity exercise. However, the scientific evidence linking rs1056827 directly to measurable athletic or cardiovascular outcomes remains limited and preliminary.
What each genotype means
Typical enzyme activity profile
This genotype represents the most common form of this variant. Research into this specific marker is limited, and it is generally considered to have a neutral impact on MTHFR-related metabolic processes.
This is the most common genotype globally, though frequencies vary significantly by ancestral background.
Common heterozygous variant profile
Carrying one copy of the T allele is a frequent observation in many populations. Current evidence regarding its functional impact on homocysteine dynamics or fitness is limited, and it is not typically associated with significant clinical outcomes.
This genotype is found in a substantial portion of the global population, consistent with the reported minor allele frequency.
Less common variant profile
Individuals with this genotype carry two copies of the T allele. While this variant is cataloged for its potential influence on vascular recovery and metabolic dynamics, the evidence remains limited and inconsistent; therefore, it should not be used to infer specific health or fitness outcomes.
This is the least common of the three genotypes, appearing at a frequency consistent with the minor allele distribution in the general population.
What is rs1056827 and Where is it Located?
The variant rs1056827 represents a single nucleotide variation situated within the MTHFR gene on chromosome 1. Human genes frequently harbor common sequence alterations known as single nucleotide polymorphisms (SNPs), many of which reflect natural genomic variation rather than severe disease-causing disruptions. While primary research historically centers on well-characterized missense changes in MTHFR such as C677T (rs1801133) and A1298C (rs1801131), secondary polymorphisms across the broader locus—including rs1056827—have increasingly appeared in functional genomics and sports genomics profiles. Polymorphisms across this gene locus can lie in coding sequences, regulatory promoter regions, or non-coding intronic sequences where they may subtly influence transcript stability, alternative splicing patterns, or baseline expression levels. Genomic databases such as dbSNP catalogue rs1056827 as an established common marker, providing a standardized coordinate system for geneticists tracing how minor genomic differences interact with broader cellular pathways.
The Biological Role of the MTHFR Gene
The MTHFR gene provides instructions for assembling the enzyme methylenetetrahydrofolate reductase, an indispensable component of the one-carbon folate-methionine cycle. This metabolic pathway converts 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate, providing the methyl donor required to remethylate homocysteine back into methionine. Methionine subsequently produces S-adenosylmethionine (SAM), the primary chemical donor required for wide-scale DNA methylation, neurotransmitter synthesis, and cellular repair mechanisms. When MTHFR enzymatic activity fluctuates or becomes constrained, intermediate metabolites—most notably plasma homocysteine—can temporarily rise. Elevated concentrations of systemic homocysteine are often studied because they can induce oxidative stress, reduce nitric oxide bioactivity, and influence vascular resistance. Because vascular compliance and efficient nutrient delivery depend closely on endothelial integrity, variation within the folate pathway provides a biological rationale for why exercise physiologists examine MTHFR sequence variation.
Research Associations and Scientific Evidence
In athletic and exercise biology, rs1056827 has been categorized under fitness and vascular recovery traits, specifically concerning endothelial restoration following high-intensity training. During strenuous physical exertion, working skeletal muscle generates significant metabolic waste, accompanied by temporary inflammatory and oxidative shifts that stress the vascular endothelium. Some preliminary studies hypothesize that polymorphisms altering homocysteine dynamics might influence how quickly endothelial function returns to resting equilibrium. However, the evidence supporting a definitive, standalone effect for rs1056827 remains limited. Broad consensus across major genetics literature emphasizes that single non-pathogenic variants in MTHFR typically exert subtle, polygenic influences rather than dramatic isolated effects. Furthermore, confounding lifestyle elements—such as dietary dietary folate intake, vitamin B12 levels, hydration, and training periodization—generally exert far stronger functional impacts on vascular health and homocysteine clearance than common non-pathogenic polymorphisms.
Population Distribution and Ancestry Patterns
According to large-scale population catalogs such as the Genome Aggregation Database (gnomAD), rs1056827 is a common variant across human populations, presenting a global minor allele frequency (MAF) of approximately 0.28 (28%). Because human evolutionary histories diverge across geographic regions, the allele distribution varies meaningfully among diverse ancestries. In cohorts of European, Hispanic, and East Asian backgrounds, common MTHFR variants generally demonstrate wide frequency variations, whereas certain African continental lineages frequently maintain different baseline allele distributions. A global MAF of nearly 30% indicates that tens of millions of healthy individuals naturally carry one or two copies of the minor allele without experiencing any overt biochemical disorder or clinical impairment. Understanding these population-level baselines helps prevent the misinterpretation of common, benign evolutionary variance as a harmful medical deficit.
What Consumers Can and Cannot Do With This Result
Receiving genetic data showing an altered genotype at rs1056827 provides educational insight into one's genetic background, but it cannot be used to diagnose a medical condition or predict physical athletic capability. Major clinical genetics bodies do not recommend utilizing common MTHFR polymorphisms to direct medical interventions, design personalized nutritional cures, or prescribe pharmacological therapies. If an individual carries genotypes associated with minor enzyme alterations, the practical implications are overwhelmingly guided by foundational health behaviors rather than genetic modifications. Ensuring adequate dietary intake of natural folates and B vitamins through whole foods (such as leafy greens, legumes, and lean proteins), maintaining consistent cardiovascular exercise, and allowing sufficient post-workout recovery support endothelial health universally. Any questions regarding systemic homocysteine testing, cardiovascular risks, or pharmaceutical management should be discussed with a qualified physician or pharmacist rather than addressed through commercial genetic scores.
How common is this variant?
According to large genomic reference datasets including gnomAD, rs1056827 has a global minor allele frequency (MAF) of approximately 0.28, reflecting widespread prevalence across continental populations.
Frequently asked questions
Does having the rs1056827 variant mean I have an MTHFR enzyme deficiency?
No, carrying a common variant like rs1056827 does not indicate severe MTHFR deficiency. True clinical MTHFR deficiency is an extremely rare metabolic condition caused by specific pathogenic mutations, whereas common polymorphisms produce at most modest variations in metabolic activity that are often clinically silent.
Can rs1056827 predict my recovery from high-intensity workouts?
Scientific evidence linking rs1056827 directly to workout recovery is limited. Although the MTHFR pathway intersects with vascular endothelial health and homocysteine metabolism, your actual exercise recovery depends far more on sleep, training intensity, hydration, and overall nutrition than on any single genetic marker.
Should I take high-dose methylated folate if I carry this variant?
No, major medical and genetic guidelines do not recommend taking specialized or high-dose supplements solely based on common MTHFR polymorphisms. Most individuals meet their nutritional needs through a standard balanced diet containing natural folate, and any supplement changes should be evaluated with a healthcare professional.
Is genetic testing for rs1056827 medically necessary?
Routine clinical guidelines do not advise testing for common MTHFR variants in asymptomatic individuals. Because common polymorphisms have high frequencies across the general population and low predictive power for multifactorial diseases, medical societies consider them uninformative for general health screening.
Sources & further reading
Educational information only, last refreshed 9/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1056827?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in MTHFR
Variant in the MTHFR locus frequently studied in association with folate metabolism and homocysteine levels.
MTHFR missense variant (c.1793G>A, p.Arg594Gln) commonly evaluated alongside canonical variants for folate metabolism and hyperhomocysteinemia predisposition.
Common variant (C677T) influencing folate metabolism and plasma homocysteine levels.
The C677T variant in the MTHFR gene is associated with reduced enzyme activity and mild hyperhomocysteinemia, particularly in individuals with low folate intake.
The MTHFR 677C>T (Ala222Val) variant encodes a thermolabile enzyme with reduced activity. While associated with elevated homocysteine levels in the presence of low folate, major professional guidelines (e.g., ACMG) advise against routine clinical testing for cardiovascular or thrombophilia risk due to lack of clinical utility.
Rare functional missense variant in MTHFR (p.Arg157Gln) associated with reduced folate pathway enzyme activity.